Follow
Separovic J, Separovic-Hanzevacki J, Hanzevacki J, Šeparović Hanževački Jadranka, Šeparović J
Separovic J, Separovic-Hanzevacki J, Hanzevacki J, Šeparović Hanževački Jadranka, Šeparović J
Other namesSeparovic Hanzevacki J, Hanzevacki JS, Jadranka Šeparović Hanževački
Professor of Cardiology, School of Medicine, University of Zagreb
Verified email at kbc-zagreb.hr
Title
Cited by
Cited by
Year
2015 ESC Guidelines for the diagnosis and management of pericardial diseases
Y Adler, P Charron, M Imazio, L Badano, G Barón-Esquivias, J Bogaert, ...
Polish Heart Journal (Kardiologia Polska) 73 (11), 1028-1091, 2015
24342015
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study.
LP Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA ...
Eur Heart J. 2019 Oct 14;40(39):3222-3232. doi: 10.1093/eurheartj/ehz620 …, 2019
583*2019
The influence of a novel pentadecapeptide, BPC 157, on NG-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure
P Sikirić, S Seiwerth, Ž Grabarević, R Ručman, M Petek, V Jagić, ...
European journal of pharmacology 332 (1), 23-33, 1997
2081997
A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC
P Sikirić, M Petek, R Ručman, S Seiwerth, Z Grabarević, I Rotkvić, ...
Journal of Physiology-Paris 87 (5), 313-327, 1993
1691993
The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A …
P Sikiric, S Seiwerth, Z Grabarevic, M Petek, R Rucman, B Turkovic, ...
Life sciences 54 (5), PL63-PL68, 1994
1611994
Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse
M Lovric-Bencic, P Sikiric, JS Hanzevacki, S Seiwerth, D Rogic, V Kusec, ...
Journal of pharmacological sciences 95 (1), 19-26, 2004
1382004
Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system
D Balenovic, ML Bencic, M Udovicic, K Simonji, JS Hanzevacki, I Barisic, ...
Regulatory peptides 156 (1-3), 83-89, 2009
1172009
Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicity
P Sikirić, S Seiwerth, Ž Grabarević, R Ručman, M Petek, V Jagić, ...
Digestive diseases and sciences 41, 1604-1614, 1996
1161996
Alterations of systolic left ventricular twist after acute myocardial infarction
J Garot, O Pascal, B Diébold, G Derumeaux, BL Gerber, JL Dubois-Randé, ...
American Journal of Physiology-Heart and Circulatory Physiology 282 (1 …, 2002
1112002
Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats
P Sikiric, S Seiwerth, Z Grabarevic, R Rucman, M Petek, V Jagic, ...
Journal of Physiology-Paris 91 (3-5), 113-122, 1997
1011997
A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
P Sikiric, A Marovic, W Matoz, T Anic, G Buljat, D Mikus, ...
Journal of Physiology-Paris 93 (6), 505-512, 1999
891999
Hepatoprotective effect of BPC 157, a 15-aminoacid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCL4 administration …
P Sikiric, S Seiwerth, Z Grabarevic, R Rucman, M Petek, I Rotkvic, ...
Life sciences 53 (18), PL291-PL296, 1993
881993
The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation
P Sikiric, J Šeparovic, T Anic, G Buljat, D Mikus, S Seiwerth, Z Grabarevic, ...
Journal of Physiology-Paris 93 (6), 479-485, 1999
851999
Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol …
I Prkacin, J Separovic, G Aralicia, D Perovic, M Gjurasin, M Lovric-Bencic, ...
Journal of Physiology-Paris 95 (1-6), 315-324, 2001
792001
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
G Habib, P Lancellotti, PA Erba, A Sadeghpour, M Meshaal, A Sambola, ...
European Heart Journal - Quality of Care and Clinical Outcomes, Volume 5 …, 2019
772019
Update of the echocardiography core syllabus of the European Association of Cardiovascular Imaging (EACVI)
B Cosyns, M Garbi, J Separovic, A Pasquet, P Lancellotti, ...
European Heart Journal–Cardiovascular Imaging 14 (9), 837-839, 2013
69*2013
Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats.
I Prkacin, G Aralica, D Perovic, J Separovic, M Gjurasin, M Lovric-Bencic, ...
Journal of Physiology-Paris 95 (1-6), 295-301, 2001
652001
Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats
P Sikirić, S Seiwerth, Ž Grabarević, R Ručman, M Petek, V Jagić, ...
Digestive diseases and sciences 41, 1518-1526, 1996
651996
Pentadecapeptide BPC 157, Cimetidine, Ranitidine, Bromocriptine, and Atropine Effect in Cysteamine Lesions in Totally Gastrectromized Rats (A Model for Cytoprotective Studies)
P Sikiric, D Mikus, S Seiwerth, Z Grabarevic, J Peric, P Konjevoda, ...
Digestive diseases and sciences 42, 1029-1037, 1997
581997
Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and …
P Sikiric, S Seiwerth, Z Grabarevic, I Balen, G Aralica, M Gjurasin, ...
Journal of Physiology-Paris 95 (1-6), 261-270, 2001
562001
The system can't perform the operation now. Try again later.
Articles 1–20